Natural 1-O-alkylglycerols reduce platelet-activating factor-induced release of [3H]-serotonin in rabbit platelets

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 71, Issue 1, 2004, Pages 19-23

  Pedrono F ^a   Cheminade, C ^a   Legrand, A B ^a  

^a UNIVERSITÉ DE RENNES 1   (France)

Author keywords

Alkylglycerols; Platelet activating factor; Platelet activation

Indexed keywords

GLYCEROL DERIVATIVE; LIPID; OIL; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLINOSITOL; SEROTONIN; THROMBIN; THROMBOCYTE ACTIVATING FACTOR; TRITIUM;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; DRUG METABOLISM; DRUG PURIFICATION; IN VITRO STUDY; LIVER; NONHUMAN; PRIORITY JOURNAL; RABBIT; SEROTONIN RELEASE; SHARK; THROMBOCYTE; TIME;

ANIMALS; BLOOD PLATELETS; GLYCERYL ETHERS; PLATELET ACTIVATING FACTOR; PLATELET ACTIVATION; PLATELET MEMBRANE GLYCOPROTEINS; PROTEIN KINASE C; RABBITS; RECEPTORS, G-PROTEIN-COUPLED; SEROTONIN; THROMBIN;

CHONDRICHTHYES; ORYCTOLAGUS CUNICULUS;

EID: 3042733576     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2003.12.003     Document Type: Article

References (35)

1. Vejar M., Fragasso G., Hackett D., Lipkin D.P., Maseri A., Born G.V., Giabattoni G., Patrono C. Dissociation of platelet activation and spontaneous myocardial ischemia in unstable angina. Thromb. Haemost. 63:1990;163-168
2. Puri V.K., Verma M., Saxema A.K., Shanker K. Platelet serotonergic mechanisms in ischaemic heart disease. Thromb. Res. 57:1990;445-451
3. Nityanand S., Tekwani B.L., Chandra M., Shanker K., Singh B.N. Kinetics of serotonin in platelets in essential hypertension. Life Sci. 46:1990;367-372
4. Guicheney P., Devynck M.A., Cloix J.F., Pernollet M.G., Grichois M.L., Meyer P. Platelet 5-HT content and uptake in essential hypertension. role of endogenous digitalis-like factors and plasma cholesterol J. Hypertens. 6:1988;873-879
5. Hervé P., Drouet L., Dosquet C., Launay J.M., Rain B., Simonneau G., Caen J., Duroux P. Primary pulmonary hypertension in a patient with a familiar platelet storage pool disease. role of serotonin Am. J. Med. 89:1990;117-120
6. Zeller J., Weissbarth E., Baruth B., Mielke H., Deicher H. Serotonin content of platelets in inflammatory rheumatic diseases. Correlation with clinical activity. Arthritis Rheum. 26:1983;532-540
7. Biondi M.L., Marasini B., Bianchi E., Agostoni A. Plasma free and intraplatelet serotonin in patients with Raynaud's phenomenon. Int. J. Cardiol. 19:1988;335-339
8. Barradas M.A., Gill D.S., Fonseca V.A., Mikhailidis D.P., Dandona P. Intraplatelet serotonin in patients with diabetes mellitus and peripheral vascular disease. Eur. J. Clin. Invest. 18:1988;399-404
9. Helland I., Klementsen B., Jorgensen L. Addition of both platelets and thrombin in combination accelerates tumor cells to adhere to endothelial cells in vitro. In vitro Cell Dev. Biol. Anim. 33:1997;182-186
10. Klementsen B., Jorgensen L. Mechanisms involved in the early interaction between HeLa cells, platelets and endothelial cells in vitro under the influence of thrombin. Effects of acetylsalicylic acid and Na-salicylate. APMIS. 105:1997;391-401
11. Pinedo H.M., Verheul H.M., D'Amoto R.J., Folkman J. Involvement of platelets in tumour angiogenesis? Lancet. 352:1998;1775-1777
12. Karpatkin S., Pearlstein E., Ambrogio C., Coller B.S. Role of adhesive proteins in platelet tumor interaction in vitro and metastasis formation in vivo. J. Clin. Invest. 81:1988;1012-1019
13. Hallgren B., Larsson S. The glyceryl ethers in the liver oils of elasmobranch fish. J. Lipid Res. 3:1962;31-38
14. Hallgren B., Larsson S. The glyceryl ethers in man and cow. J. Lipid Res. 3:1962;39-43
15. Brohult A., Brohult J., Brohult S., Joelsson I. Effect of alkoxyglycerols on the frequency of injuries following radiation therapy for carcinoma of the uterine cervix. Acta Obstet. Gynecol. Scand. 56:1977;441-448
16. Brohult A., Brohult J., Brohult S. Regression of tumor growth after administration of alkoxyglycerols. Acta Obstet. Gynecol. Scand. 57:1978;79-83
17. Brohult A., Brohult J., Brohult S., Joelsson I. Reduced mortality in cancer patients after administration of alkoxyglycerols. Acta Obstet. Gynecol. Scand. 65:1986;779-785
18. Linman J.W. Hemopoietic effects of glyceryl ethers. III. Inactivity of selachyl alcohol. Proc. Soc. Exp. Biol. Med. 104:1960;703-706
19. Homma S., Yamamoto N. Activation process of macrophages after in vivo treatment of mouse lymphocytes with dodecylglycerol. Clin. Exp. Immunol. 79:1990;307-313
20. Ngwenya B.Z., Foster D.M. Enhancement of antibody production by lysophosphatidylcholine and alkylglycerol. Proc. Soc. Exp. Biol. Med. 196:1991;69-75
21. Oh S.Y., Jadhav L.S. Effects of dietary alkylglycerols in lactating rats on immune responses in pups. Pediatr. Res. 36:1994;300-305
22. Cheminade C., Gautier V., Hichami A., Allaume P., Le Lannou D., Legrand A.B. 1-O-alkylglycerols improve boar sperm motility and fertility. Biol. Reprod. 66:2002;421-428
23. Marigny K., Pédrono F., Martin-Chouly C.A.E., Youmine H., Saïag B., Legrand A.B. Modulation of endothelial permeability by 1-O-alkylglycerols. Acta Physiol. Scand. 176:2002;263-268
24. Hichami A., Duroudier V., Leblais V., Vernhet L., Le Goffic F., Ninio E., Legrand A. Modulation of platelet-activating-factor production by incorporation of naturally occurring 1-O-alkylglycerols in phospholipids of human leukemic monocyte-like THP-1 cells. Eur. J. Biochem. 250:1997;242-248
25. Heymans F., Da Silva C., Marrec N., Godfroid J.J., Castagna M. Alkyl analogs of diacylglycerol as activators of protein kinase C. FEBS Lett. 218:1987;35-40
26. Daniel L.W., Small G.W., Schmitt J.D., Marasco C.J., Ishaq K., Piantadosi C. Alkyl-linked diglycerides inhibit protein kinase C activation by diacylglycerols. Biochem. Biophys. Res. Commun. 151:1988;291-297
27. Braquet P., Touqui L., Shen T.Y., Vargaftig B.B. Perspectives in platelet-activating factor research. Pharmacol. Rev. 39:1987;97-145
28. Chignard M., Le Couedic J.P., Tencé M., Vargaftig B.B., Benveniste J. The role of platelet-activating factor in platelet aggregation. Nature. 279:1979;799-800
29. Chao W., Olson M.S. Platelet-activating factor. receptors and signal transduction Biochem. J. 292:1993;617-629
30. Le Blanc K., Samuelsson J., Brohult J., Berg A., Palmblad J. 1-O-hexadecyl-2-methoxy-glycero-3-phosphatidylcholine - a methoxy ether lipid inhibiting platelet activating factor-induced platelet aggregation and neutrophil oxydative metabolism. Biochem. Pharmacol. 49:1995;1577-1582
31. Bossant M.J., Ninio E., Delautier D., Benveniste J. Bioassay of paf-acether by rabbit platelet aggregation. Methods Enzymol. 187:1990;125-130
32. Bligh E.G., Dyer W.J. Arapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37:1959;911-917
33. Ardlie N.G., Packham M.A., Mustard J.F. Adenosine diphosphate-induced platelet aggregation in suspensions of washed rabbit platelets. Br. J. Haematol. 19:1970;7-17
34. Pugliese P.T., Jordan K., Cederberg H., Brohult J. Some biological actions of alkylglycerols from shark liver oil. J. Altern. Complement Med. 4:1998;87-99
35. Robinson M., Burdine R., Warne T.R. Inhibition of phorbol ester-stimulated arachidonic acid release by alkylglycerols. Biochim. Biophys. Acta. 1254:1995;361-367